Accelerate the construction of the "ecosystem" of Alzheimer's disease management to help reduce the burden on social

September 21 is "World Alzheimer's Day". Alzheimer's disease (AD) is a degenerative disease of the nervous system. Capability, communication ability, and self -care ability make patients and their families bear multiple pressures such as economy and psychology, and bring a heavy burden on the medical system and society.

Jin Chunlin, Director of Shanghai Health and Healthy Development Research Center

Jin Chunlin, director of the Shanghai Health and Healthy Development Research Center, pointed out that Alzheimer's social and economic burden is heavy. At present, the care institutions of our country are far from meeting patient needs, and the protection of patient care is also lacking. Secondly, patients with low visits in my country, especially those with mild cognitive impairment, have lower visits. How to solve the early diagnosis, clinic and even guarantee of the patients with Alzheimer's disease is a topic that needs to be concerned about society.

Grasp the "Opportunity Window Period"

It is urgent to promote "early screening early intervention"

The elderly population has continued to increase, and the long -term patient management test brought by brain health problems has a profound impact on the sustainable development of public service and social security systems. China has the world's most Alzheimer's patients, and the prevalence and incidence are high. Data show that with the deepening of society's aging, the number of patients with Alzheimer's disease in my country may climb to more than 30 million in 2050.

In contrast to the huge group of disease groups, the public's awareness of Alzheimer's disease is still scarce. The prejudice and stereotype of the disease hinders the patient's early consultation, and the delayed diagnosis and intervention have led to a decrease in the survival time and the patient's survival time. The quality of life has decreased and the cost of social medical care has increased, and there are still a large number of unsatisfactory clinical needs in this area.

Director Jin Chunlin told reporters in the interview that Alzheimer's disease in my country is facing the "three lows" situation, namely low cognitive level, low consultation rate, and low treatment rate. "The aging process is continuously accelerated so that the number of patients who need to be taken care of is increasing at an unprecedented rate. The" supply in shortness "is the most important contradiction in Alzheimer's disease. Intervention methods, patient management resources show a long -term shortage situation. "

In addition, the economic burden of Alzheimer's disease cannot be underestimated. Because patients are usually accompanied by damage to daily life and abnormal mental behavior, they not only seriously affect their physical and mental health and quality of life, but also bring heavy long -term care and economic burden to families and society.

Director Jin Chunlin said that patients with Alzheimer's disease have a long survival time, comprehensively counting their direct medical burden, direct non -medical burden, and indirect economic burden. Chinese patients have an annual economic burden of nearly 130,000 yuan. Due to the working time of the patients who care for patients, the data statistics, the caregiver needs an average of 47 hours of working hours a week to take care of the patient, the cost is quite high.

Faced with increasingly increasingly ill groups, the state's attention to cognitive impaired diseases represented by Alzheimer's disease is getting higher and higher. "Health China Action (2019-2030)" proposes to increase the increase in the prevalence of dementia at the age of 65 and above from 2022 and 2030; In the pilot area, the public's awareness rate of the knowledge of dementia prevention in the pilot area increased to 80%, and the cognitive function screening rate of the elderly (village) for the elderly (village) reached 80%.

Director Jin Chunlin believes that Alzheimer's illness is hidden. Most of the patients have missed the best intervention period when consulting. Effective health intervention can slow down the number of patients with Alzheimer's disease, which greatly reduces family and social burdens.

At the same time, Director Jin Chunlin also emphasized that digital therapy may bring new opportunities for future diagnosis and treatment of Alzheimer's disease. With the development of a series of technical means such as AI and wearable devices, it is expected to provide more help for early screening of diseases and long -term care for patients.

Patients need to do it first

Build a "ecosystem" of disease management

In fact, the nervous system, including Alzheimer's disease, has always been one of the most difficult disease fields. The establishment of an effective screening mechanism is still the key to the increase in the number of patients with Alzheimer's disease. The current situation of Alzheimer's disease is urgently needed to use more efficient and more standardized management models to improve the current situation of high incidence and difficulty in control.

Director Jin Chunlin suggested that the social level should be increased to create a social atmosphere of cognitive illness. At the policy level, the prevention and control of Alzheimer's disease is listed as a priority of health China. At the same time, accelerate the development of the treatment plan in the disease field. On the basis of clarifying the early intervention of Alzheimer's disease, piloting early screening of the disease and incorporating it into basic public health service items.

In recent years, my country has carried out a lot of work on the social prevention mission of Alzheimer's disease, such as strengthening knowledge propaganda, early screening, organizational prevention intervention, etc., and successively organized 15 provinces to carry out the pilot work of the elderly's disability prevention and intervention pilot work. Essence Further improving China's Alzheimer's disease prevention and control system still depends on the governments, medical service systems, enterprises and families and other subjects to play a role and play the power of "ecosystem".

Improve the "three lows" of Alzheimer's disease in my country, and build a social support system with dignified, autonomous, and inclusive Alzheimer's disease. It also requires the support and investment of enterprises. Roche is one of the representatives. Relying on the foundation and strength of long -term cultivation in the field of neuroscience, Roche entered the field of Alzheimer's disease early. In terms of innovation research and development, in July this year, the FDA awarded Roche's amyloid -like protein blood diagnostic product breakthrough medical device identification; at the International Conference of the Alzheimer Disease Association recently held, Roche developed Aβ protein monoclonal antibody GANTENENERMAB It also announced the results of inspiring people's hearts, which entered the dawn for the clinical treatment of the disease. In terms of social support, Roche actively establishes in -depth cooperation with core related parties. For example, the health system of Alzheimer's health system should be carried out with the relevant public health expert team, and the AD community screening project in related pilot areas has been cooperated in relevant pilot areas to help the country's land prevention work. Focusing the unsatisfactory clinical needs, the current problem that is urgent to solve is to further optimize the positive innovation incentive mechanism, thereby highlighting the value of medical core services. Director Jin Chunlin believes that if you invest in huge time, resources and cost creation, new technologies and new drugs cannot be used for clinical use because of prices, which is very regrettable. "The whole society needs to work together to create a better innovation environment and launch more innovative incentive measures. At the same time, enterprises also need to fully consider China's national conditions. Everyone can work together to accelerate patients with innovative medical solutions."

Experts suggest that the establishment of an effective Alzheimer's disease management system should start from many aspects such as medical ecology and social ecology: standardize clinical diagnosis and treatment, reduce subjective diagnosis, strengthen early diagnosis and early intervention; build a technical ecosystem, strengthen technology introduction, and introduce technology introduction. And give corresponding cost subsidies; valuable diagnosis and treatment methods are put into use in clinic as soon as possible, completing a win -win situation of social, hospitals, enterprises, and patients, forming a virtuous step, encouraging research and development investment; improving the level of social nursing, cultivating standardized caregivers; further further; further further Improve the basic medical insurance system, actively develop commercial health insurance, and establish a long -term elderly disabled care insurance system; give full play to the role of associations and professional social organizations to form a comprehensive ecology of diverse subjects.

Edit: Liu Xiaomei

- END -